Miscommunication during patient handover can jeopardize patient safety and is the focus of
Quality Improvement initiatives by many organizations. It is widely recognized that such
miscommunication is preventable using a number of strategies identified in the literature.
Currently, there is no formal handover process of General Internal Medicine in-patients,
otherwise known as the Clinical Teaching Unit (CTU) at Vancouver General Hospital, which is
a major ... Read More
To develop a score that can predict early from diagnosis of Clostridium difficile infection
(CDI) the risk for relapse and of unfavorable outcome. This score can be used in the future
to identify patients will benefit from fidaxomicin treatment.
The purpose of this study is to explore the efficacy and safety of everolimus administered
as a first-line treatment in newly-diagnosed patients with advanced or inoperable
Gastrointestinal (GI) or pancreatic neuroendocrine tumors.
The study is being conducted to compare the effect of standard treatment (target LDL-C
level: <120 mg/dL (JASGL 2007 target level)) and intensive treatment (target LDL-C level:
<70 mg/dL) in the prevention of major adverse cardiac events (MACE) in hypercholesterolemia
patients with concomitant type 2 diabetes and hypertension.
A national cross-sectional survey was conducted to evaluate recommendations on clinical
preventive services and additional information on non-communicable disease prevention.
Trained surveyors interviewed interns, residents and attendings of the Internal Medicine
departments of all teaching hospitals in Guatemala. Analysis compared recommendation
practices within and between hospitals.
Several studies have shown the importance of Telephone follow-up in reducing hospital
readmissions for heart failure. Therefore, we aimed in this cohort to investigate whether
telephone follow-up with patients discharged from the general internal department improves
patients' satisfaction, increases compliance to treatment and reduces adverse effects.
Patients are recruited from the department of general internal medicine who gave informed
consent and could ... Read More
As increasing tidal volume, the cross sectional area and circumference of Internal Jugular
Vein (IJV) could increase. And In the previous study, Trendelenburg position can increase
size of IJV. So investigators would compare the cross sectional area, circumference of IJV
and peak airway pressure in neutral and Trendelenburg position
This trial is a study on all-trans retinoic acid in combination with induction and
consolidation therapy as well as pegfilgrastim after consolidation therapy in younger
patients with newly diagnosed acute myeloid leukemia (AML).
The purpose of this study is to determine whether gemcitabine and pazopanib are effective in
the treatment of inoperable, locally advanced or metastatic biliary tree cancer
(cholangiocarcinoma or gallbladder carcinoma).
The purpose of this study is to learn whether atacicept treatment leads to improvement in
kidney function in subjects with active lupus nephritis in combination with mycophenolate
mofetil (MMF) and corticosteroids. The study was sponsored by Merck Serono International;
operational oversight was provided by ZymoGenetics.
The purpose of the study is to determine the effect and optimum dose and evaluate the safety
of ferric citrate, administered three times daily (TID) immediately after meals for a total
daily dose of 4 or 6 grams for 56 days, on serum phosphate (PO4) levels in subjects with end
stage renal disease (ESRD).
This study aims to evaluate the asthma control status, asthma symptoms (severity, frequency,
and limitations on activities, etc.), QOL, and use of drugs for asthma attack in adult
The purpose of this study is to evaluate the efficacy and safety of the combination of
Cisplatin,5-Fluorouracil(5FU) and Afatinib as first-line therapy in patients with advanced
gastric or gastroesophageal junction cancer. The study will include 55 patients in all. The
patients will receive open-label Cisplatin intravenous 75mg/m2 on Day 1, 5FU 750mg/m2 at
24-hour intravenous infusion on Days 1-4, and Afatinib 40mg per os on Days 3-5, 8-12, 15-19.
The ... Read More
The purpose of this study is to proof increasing patient satisfaction and preservation of
quality of life in patients with Morbus Fabry disease receiving their Enzyme Replacement
Therapy with Replagal (Agalsidase alfa) at home compared to receiving the infusions at the
clinic or at doctor's practice.
In order to better communicate personal risk of breast cancer to women who have not yet
initiated breast cancer screening (mammography), The Annenberg School of Communication at
the University of Pennsylvania has created a personal breast cancer screening decision aid
tool. This tool will be pilot tested, and then implemented and tested in nine primary care
and OB/GYN practices within the University of Pennsylvania Health System.